Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-21-000112
Filing Date
2021-09-21
Accepted
2021-09-21 17:12:50
Documents
1
Period of Report
2021-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163225875664674.html 4  
1 FORM 4 wf-form4_163225875664674.xml 4 3611
  Complete submission text file 0001626199-21-000112.txt   5178
Mailing Address NO. 14 EAST HUSHAN ROAD TAI'AN CITY SHANDONG F4 000000
Business Address
Cui Xiangmin (Reporting) CIK: 0001487815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 211267177

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations